You are here

siltuximab

J&J’s Drug Shows Promise for Rare Castleman Disease

Bloomberg

Sun, 12/8/13 - 12:20 pm

multicentric Castleman disease

Simultaneous Applications Submitted to EMA and FDA for Siltuximab for the Treatment of Multicentric Castleman Disease, a Rare Blood Disorder

Reuters

Tue, 09/3/13 - 10:43 am

multicentric Castleman disease